Major pathways disrupted in DM1 include (1) AKT/mTOR, (2) AMPK, (3) PKC, and (4) MEK/ERK, along with downstream effectors like CUG-BP1 [79]. The gene discussed is MAP2K7; the disease is myotonic dystrophy type 1.